Hibernating control cells or why inflammations become chronic

August 10, 2017, University of Erlangen-Nuremberg

Rheumatoid arthritis is the most common autoimmune disease of the joints. It causes a chronic inflammatory response, with the body's own immune cells attacking the joint, including the cartilage and bone. This process does not cease spontaneously. An international research team headed by the rheumatologist Dr Andreas Ramming at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has now managed to identify an immune system cell type that can be used in a targeted attempt to control the inflammatory response in arthritis patients. The results obtained by the research team at Department of Medicine 3 - Rheumatology and Immunology of Universitätsklinikum Erlangen - have been published in Nature Medicine.

In Germany some 800,000 people, preliminarily women, suffer from . This causes persistent inflammation that damages the joints and bones. Patients suffer pain and experience restrictions in terms of their mobility. "A particularly worrying aspect for those affected is the fact that the in joints is exceptionally chronic and thus usually requires lifelong treatment," explains Prof. Georg Schett, director of the Department of Medicine 3.

Cells known as usually manage the resolution of inflammations.

However, to date, little has been known about how inflammations clear up and why this process does not work in those suffering from rheumatism. Now a joint project involving researchers in London, Barcelona, Zurich, Indianapolis and Dublin has now enabled the researchers in Erlangen to solve this mystery. According to Simon Rauber, an immunologist in Erlangen and primary author of the study, a previously inadequately studied cell population of the immune system called innate lymphoid cells plays a major role in the resolution of inflammations.

It seems that innate lymphoid cells go into a kind of 'hibernation' in patients with rheumatism.

"In patients suffering from rheumatoid arthritis, these innate lymphoid cells are in a state of what can be described as hibernation and as a result the inflammation persists. When innate lymphoid cells are 'woken up', this puts a stop to the inflammation and to the damage to the joint," adds principal investigator Dr Ramming. The discovery of this important mechanism could provide the opportunity to develop completely new options for treating .

New forms of treatment monitoring

Even at this stage, measuring the number of innate lymphoid cells in the blood makes it possible to provide a prognosis of the effects of treatment. If there are few innate lymphoid cells in the blood, the disease will flare up and the joint will be further damaged. However, resolution of inflammation is associated with an elevation in the number of these cells. The measurement of blood levels makes it possible to initiate individual, more targeted treatment at an early stage, thus preventing another flare-up of the disease. "These findings will make it possible to significantly improve the quality of treatment of rheumatoid arthritis in future with the help of innate lymphoid cells," says Dr Ramming.

Together against inflammation

"Collaborative Research Centre 1181 at Universitätsklinikum Erlangen and the priority programme 'Innate Lymphoid Cells' (SPP 1937) of the German Research Foundation (DFG) have made a decisive contribution to revealing this central immunological mechanism involved in the resolution of inflammations," concludes Prof. Schett. The results of this study have been published in the journal Nature Medicine in an article entitled 'Resolution of by interleukin-9-producing type 2 innate lymphoid '.

Explore further: Innate lymphoid cells elicit T cell responses

More information: Simon Rauber et al, Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells, Nature Medicine (2017). DOI: 10.1038/nm.4373

Related Stories

Innate lymphoid cells elicit T cell responses

August 18, 2014
In case of an inflammation the body releases substances that increase the immune defense. During chronic inflammation, this immune response gets out of control and can induce organ damage.

How the body stops the type 2 innate immune response from triggering allergic disease

November 23, 2015
The innate immune response, which is the body's non-specific response to pathogens, was once believed to be a simple system relying on short-lived effector cells alone, but it is now known to be more complex, involving long-lived ...

Scientists discover new mechanism that leads to inflammation in rheumatoid arthritis

March 2, 2017
New research findings published in the Journal of Leukocyte Biology, suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients. ...

New clues found to immune system's misfiring in autoimmune diseases

June 2, 2016
A person's genetic makeup plays a role in autoimmune diseases such as multiple sclerosis that develop when the body is attacked by its own immune system. But little is known about how immune cells are pushed into overdrive.

Rebooting the system: Immune cells repair damaged lung tissues after flu infection

October 3, 2011
There's more than one way to mop up after a flu infection. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania report in Nature Immunology that a previously unrecognized population of lung ...

Scientists discover molecule that does double duty in stopping asthma attacks

February 27, 2013
Scientists from Brigham and Women's Hospital are on the brink of the next treatment advancement that may spell relief for the nearly nineteen million adults and seven million children in the United States suffering from asthma. ...

Recommended for you

Machine learning tool predicts the potential of peptides as immune activators

October 23, 2018
The immune system keeps T cells under control by regulating precisely when they can respond to a pathogen. For instance, helper T cells only turn "on" if other immune cells, such as antigen-presenting cells (APCs) present ...

A new mechanism in the control of inflammation

October 18, 2018
After infection or tissue injury, the inflammatory immune response attacks the infection and repairs the damaged tissue. However, sometimes excess inflammation can have the opposite effect, increasing injury in a process ...

Sugar, a 'sweet' tool to understand brain injuries

October 15, 2018
Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

Microbiome profiling reveals associations with ulcerative colitis severity, treatment

October 11, 2018
A study of gut microbes from more than 400 children points to how the microbiome behaves in this inflammatory bowel disease.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression

October 4, 2018
Crohn's disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any part of the alimentary tract from the mouth to the anus can be affected ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.